Multiple Sclerosis Clinical Trial
Study of SPARC1103 in Subjects With Spasticity
Summary
Study of SPARC1103 in subjects with spasticity
Eligibility Criteria
Inclusion Criteria:
Men and women greater than or equal to 18 years of age
Willing to sign the informed consent form
Women of child bearing potential willing to practice an acceptable method of birth control
Known history of spasticity due to MS
Exclusion Criteria:
Administration of an investigational drug or device within 30 days prior to Screening Visit 1
Unable to comply with trial procedures in the opinion of the Investigator
Concomitant neurologic conditions causing spasticity
Any medical condition, including psychiatric disease or epilepsy, which would interfere with the interpretation of the trial results
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Long Beach California, , United States
San Diego California, , United States
Aurora Colorado, , United States
Jacksonville Florida, , United States
Miami Springs Florida, , United States
Miami Florida, , United States
Orlando Florida, , United States
Tampa Florida, , United States
Kansas City Kansas, , United States
Lenexa Kansas, , United States
Bingham Farms Michigan, , United States
Albuquerque New Mexico, , United States
Charlotte North Carolina, , United States
Cleveland Ohio, , United States
Richland Washington, , United States
Moscow , , Russian Federation
Nizhniy Novgorod , , Russian Federation
Samara , , Russian Federation
Smolensk , , Russian Federation
Ufa , , Russian Federation
Dnepropetrovsk , , Ukraine
Ivano-Frankivs'k , , Ukraine
L'viv , , Ukraine
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.